Menglin Xu
Wuhu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Akkermansia muciniphila supports anti-PD-1 therapy in colorectal cancer: Butyrate-associated metabolic changes and CD8⁺ T-cell responses.
Journal: Pathology, research and practice
Published: January 10, 2026
Decoy Extracellular Vesicles Overcome Triple-Negative Breast Cancer Heterogeneity via Membrane-Cytoplasm-Mitochondria Cascade Targeting.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 10, 2025
Prognosis significance and potential association between ALDOA and AKT expression in colorectal cancer.
Journal: Scientific reports
Published: September 03, 2023
Prognosis value and positive association of Rab1A/IL4Rα aberrant expression in gastric cancer.
Journal: Scientific reports
Published: November 28, 2022
Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT-mTOR pathway.
Journal: Molecular carcinogenesis
Published: October 22, 2022
AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
Journal: Aging
Published: June 30, 2020
Yes-Associated Protein Contributes to Cell Proliferation and Migration of Gastric Cancer via Activation of Gli1.
Journal: OncoTargets and therapy
Published: June 06, 2020
Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer.
Journal: Scientific reports
Published: April 16, 2020
ENO1 Acts as a Prognostic Biomarker Candidate and Promotes Tumor Growth and Migration Ability Through the Regulation of Rab1A in Colorectal Cancer.
Journal: Cancer management and research
Published: August 07, 2019
Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
Journal: Oncology reports
Published: February 14, 2019
Last Updated: 09/26/2026